Nutraceuticals are bioactive or chemical compounds acclaimed for their valuable biological activities and health‐promoting effects. The global community is faced with many health concerns such as cancers, cardiovascular and neurodegenerative diseases, diabetes, arthritis, osteoporosis, etc. The effect of nutraceuticals is similar to pharmaceuticals, even though the term nutraceutical has no regulatory definition. The usage of nutraceuticals, to prevent and treat the aforementioned diseases, is limited by several features such as poor water solubility, low bioavailability, low stability, low permeability, low efficacy, etc. These downsides can be overcome by the application of the field of nanotechnology manipulating the properties and structures of materials at the nanometer scale. In this review, the linear and cyclic dextrin, formed during the enzymatic degradation of starch, are highlighted as highly promising nanomaterials‐ based drug delivery systems. The modified cyclic dextrin, cyclodextrin (CD)‐based nanosponges (NSs), are well‐known delivery systems of several nutraceuticals such as quercetin, curcumin, resveratrol, thyme essential oil, melatonin, and appear as a more advanced drug delivery system than modified linear dextrin. CD‐based NSs prolong and control the nutraceuticals release, and display higher biocompatibility, stability, and solubility of poorly water‐soluble nutraceuticals than the CD-inclusion complexes, or uncomplexed nutraceuticals. In addition, the well‐explored CD‐based NSs pathways, as drug delivery systems, are described. Although important progress is made in drug delivery, all the findings will serve as a source for the use of CD‐based nanosystems for nutraceutical delivery. To sum up, our review introduces the extensive literature about the nutraceutical concepts, synthesis, characterization, and applications of the CD‐based nano delivery systems that will further contribute to the nutraceutical delivery with more potent nanosystems based on linear dextrins.

Nutraceutical Concepts and Dextrin‐Based Delivery Systems

Hoti G.
First
;
Matencio Duran A.;Pedrazzo Rubin Alberto.;Cecone C.;Appleton S. L.;Caldera F.;Trotta Francesco.
Last
2022-01-01

Abstract

Nutraceuticals are bioactive or chemical compounds acclaimed for their valuable biological activities and health‐promoting effects. The global community is faced with many health concerns such as cancers, cardiovascular and neurodegenerative diseases, diabetes, arthritis, osteoporosis, etc. The effect of nutraceuticals is similar to pharmaceuticals, even though the term nutraceutical has no regulatory definition. The usage of nutraceuticals, to prevent and treat the aforementioned diseases, is limited by several features such as poor water solubility, low bioavailability, low stability, low permeability, low efficacy, etc. These downsides can be overcome by the application of the field of nanotechnology manipulating the properties and structures of materials at the nanometer scale. In this review, the linear and cyclic dextrin, formed during the enzymatic degradation of starch, are highlighted as highly promising nanomaterials‐ based drug delivery systems. The modified cyclic dextrin, cyclodextrin (CD)‐based nanosponges (NSs), are well‐known delivery systems of several nutraceuticals such as quercetin, curcumin, resveratrol, thyme essential oil, melatonin, and appear as a more advanced drug delivery system than modified linear dextrin. CD‐based NSs prolong and control the nutraceuticals release, and display higher biocompatibility, stability, and solubility of poorly water‐soluble nutraceuticals than the CD-inclusion complexes, or uncomplexed nutraceuticals. In addition, the well‐explored CD‐based NSs pathways, as drug delivery systems, are described. Although important progress is made in drug delivery, all the findings will serve as a source for the use of CD‐based nanosystems for nutraceutical delivery. To sum up, our review introduces the extensive literature about the nutraceutical concepts, synthesis, characterization, and applications of the CD‐based nano delivery systems that will further contribute to the nutraceutical delivery with more potent nanosystems based on linear dextrins.
2022
23
8
4102
4122
cyclic dextrin; disease; drug delivery; linear dextrin; nanosponges; nano‐carrier; nutraceutical delivery; nutraceuticals; starch; Biological Availability; Dietary Supplements; Drug Delivery Systems; Water; Cyclodextrins; Dextrins
Hoti G.; Matencio Duran A.; Pedrazzo Rubin Alberto.; Cecone C.; Appleton S.L.; Monfared Y.K.; Caldera F.; Trotta Francesco.
File in questo prodotto:
File Dimensione Formato  
ijms-23-04102.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 2.97 MB
Formato Adobe PDF
2.97 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1869033
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 22
social impact